Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A2 and 5-lipoxygenase catalyzed pathway

Oncogene

Volumn 21, Issue 37, 2002, Pages 5765-5772

  Taylor, Paul M ^a   Woodfield, Richard J ^a   Hodgkin, Matthew N ^a,b   Pettitt, Trevor R ^a   Martin, Ashley ^a   Kerr, David J ^a,c   Wakelam, Michael J O ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

5 lipoxygenase; Breast cancer cell; EMMPRIN; Fibroblast; MMP2; Phospholipase A2

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CD147 ANTIGEN; GELATINASE A; MEMBRANE PROTEIN; PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; FIBROBLAST; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, CD147; ANTIGENS, NEOPLASM; ARACHIDONATE 5-LIPOXYGENASE; BREAST NEOPLASMS; CATALYSIS; FEMALE; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASE 2; MEMBRANE GLYCOPROTEINS; PHOSPHOLIPASES A; TUMOR CELLS, CULTURED;

EID: 0037158892     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205702     Document Type: Article

References (24)

1. Balsinde J and Dennis EA. (1996). J. Biol. Chem., 271, 6758-6765.
2. Bassett P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC and Chambon P. (1990). Nature, 348, 699-704.
3. Berditchevski F, Chang S, Bodorova J and Hemler ME. (1997). J. Biol. Chem., 272, 29174-29180.
4. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H and Nabeshima K. (1995). Cancer Res., 55, 434-439.
5. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, d'Ortho MP and Murphy G. (1998). J. Biol. Chem., 273, 871-880.
6. Caudroy S, Polette M, Tournier JM, Burlett H, Toole B, Zucker B and Birembaut P. (1999). J. Histochem. Cytochem., 47, 1575-1580.
7. D'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG and Grigioni WF. (1991). Mod. Pathol., 4, 239-246.
8. DeCastro R, Zhang Y, Guo HM, Kataoka H, Gordon MK, Toole BP and Biswas C. (1996). J. Invest. Dermatol., 106, 1260-1265.
9. Ellis SM, Nabeshima K and Biswas C. (1989). Cancer Res., 49, 3385-3391.
10. Ferry DR, Deakin M, Baddeley J, Daryanani S, Bramhall S, Anderson DA, Wakelam MJO, Doran J, Pemberton G, Young AM, Buckels J and Kerr DJ. (2000). Ann. Oncol., 11, 1165-1170.
11. Guo H, Zucker S, Gordon MK, Bryan BP and Biswas C. (1997). J. Biol. Chem., 272, 24-27.
12. Huang MT, Newmark HL and Frenkel K. (1997). J. Cell. Biochem. Suppl. 27: 26-34.
13. Kleiner DE and Stetler-Stevenson WG. (1999). Cancer Chemother. Pharmacol., 43, 42-51.
14. Light DB, Mertins TM, Belongia JA and Witt CA. (1997). J. Membr. Biol., 158, 229-239.
15. Lim M, Martinez T, Jablons D, Cameron R, Guo H, Toole B, Li J and Basbaum C. (1998). FEBS Letters, 441, 88-92.
16. Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, Kasahara N, Raizman MB and Fini ME. (2000). J. Biol. Chem., 275, 10405-10412.
17. Nabeshima K, Lane WS and Biswas C. (1991). Arch. Biochem. Biophys, 285, 90-96.
18. Nomura H, Sato H, Seiki M, Mai M and Okada Y. (1995). Cancer Res., 55, 3263-3266.
19. Sternlicht MD, Lochter A, Sympson CJ, Juey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ and Werb Z. (1999). Cell, 98, 137-146.
20. Sun JX and Hemler ME. (2001). Cancer Res., 61, 2276-2281.
21. Ward RV, Atkinson SJ, Reynolds JJ and Murphy G. (1994). Biochem. J., 304, 263-269.
22. Winstead MV, Balsinde J and Dennis EA. (2000). Biochim. Biophys. Acta, 1488, 28-39.
23. Zeng ZS, Cohen AM and Guillem JG. (1999). Carcinogenesis, 20, 749-755.
24. Zucker S, Hymowitz M, Rollo EE, Mann R, Conner CE, Cao J, Foda HD, Tompkins DC and Toole BP. (2001). Am. J. Pathol., 158, 1921- 1928.